Cleared Special

K150235 - CLEARSIGN II Amplifier, 40 channels, CLEARSIGN II Amplifier, 80 channels, CLEARSIGN II Amplifier, 120 channels, CLEARSIGN II Amplifer, 160 channels (FDA 510(k) Clearance)

Apr 2015
Decision
79d
Days
Class 2
Risk

K150235 is an FDA 510(k) clearance for the CLEARSIGN II Amplifier, 40 channels, CLEARSIGN II Amplifier, 80 channels, CLEARSIGN II Amplifier, 120 channels, CLEARSIGN II Amplifer, 160 channels. This device is classified as a Amplifier And Signal Conditioner, Transducer Signal (Class II - Special Controls, product code DRQ).

Submitted by Boston Scientific Corporation (Lowell, US). The FDA issued a Cleared decision on April 22, 2015, 79 days after receiving the submission on February 2, 2015.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2060.

Submission Details

510(k) Number K150235 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2015
Decision Date April 22, 2015
Days to Decision 79 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRQ — Amplifier And Signal Conditioner, Transducer Signal
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2060